company background image
IATR

Athens Medical C.S.AATSE:IATR Stock Report

Market Cap

€143.5m

7D

-6.5%

1Y

18.2%

Updated

26 Nov, 2021

Data

Company Financials
IATR fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health3/6
Dividends0/6

IATR Stock Overview

Athens Medical C.S.A., together with its subsidiaries, owns and operates hospital units in Greece and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Athens Medical C.S.A
Historical stock prices
Current Share Price€1.66
52 Week High€1.96
52 Week Low€1.28
Beta1.27
1 Month Change-4.34%
3 Month Change-11.73%
1 Year Change18.21%
3 Year Change65.50%
5 Year Change171.76%
Change since IPO-4.92%

Recent News & Updates

Oct 04
Athens Medical C.S.A (ATH:IATR) Seems To Use Debt Quite Sensibly

Athens Medical C.S.A (ATH:IATR) Seems To Use Debt Quite Sensibly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Aug 12
There's Been No Shortage Of Growth Recently For Athens Medical C.S.A's (ATH:IATR) Returns On Capital

There's Been No Shortage Of Growth Recently For Athens Medical C.S.A's (ATH:IATR) Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

May 07
There May Be Reason For Hope In Athens Medical C.S.A's (ATH:IATR) Disappointing Earnings

There May Be Reason For Hope In Athens Medical C.S.A's (ATH:IATR) Disappointing Earnings

Soft earnings didn't appear to concern Athens Medical C.S.A.'s ( ATH:IATR ) shareholders over the last week. We did...

Shareholder Returns

IATRGR HealthcareGR Market
7D-6.5%-4.3%-5.8%
1Y18.2%-1.7%-20.9%

Return vs Industry: IATR exceeded the Greek Healthcare industry which returned 2.1% over the past year.

Return vs Market: IATR exceeded the Greek Market which returned -16.4% over the past year.

Price Volatility

Is IATR's price volatile compared to industry and market?
IATR volatility
IATR Average Weekly Movement4.3%
Healthcare Industry Average Movement4.0%
Market Average Movement4.2%
10% most volatile stocks in GR Market6.8%
10% least volatile stocks in GR Market2.7%

Stable Share Price: IATR is not significantly more volatile than the rest of Greek stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: IATR's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19843,147Vassilios Apostolopouloshttps://www.athexgroup.gr/company-profile/-/select-company/230

Athens Medical C.S.A., together with its subsidiaries, owns and operates hospital units in Greece and internationally. The company offers diagnosis and treatment for breast, gastrointestinal, hematologic, liver and pancreatic, lungs, prostate, skin, bladder and kidney, and gynecological cancers; and robotic, and neurosurgeons and spine surgery services, as well as treatments for heart diseases. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions.

Athens Medical C.S.A Fundamentals Summary

How do Athens Medical C.S.A's earnings and revenue compare to its market cap?
IATR fundamental statistics
Market Cap€143.55m
Earnings (TTM)€12.31m
Revenue (TTM)€221.21m

11.7x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IATR income statement (TTM)
Revenue€221.21m
Cost of Revenue€167.20m
Gross Profit€54.02m
Expenses€41.70m
Earnings€12.31m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.14
Gross Margin24.42%
Net Profit Margin5.57%
Debt/Equity Ratio153.6%

How did IATR perform over the long term?

See historical performance and comparison

Valuation

Is Athens Medical C.S.A undervalued compared to its fair value and its price relative to the market?

11.66x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: IATR (€1.66) is trading above our estimate of fair value (€0.71)

Significantly Below Fair Value: IATR is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: IATR is good value based on its PE Ratio (11.7x) compared to the European Healthcare industry average (19.5x).

PE vs Market: IATR is good value based on its PE Ratio (11.7x) compared to the Greek market (14.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IATR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IATR is good value based on its PB Ratio (1.6x) compared to the XE Healthcare industry average (2.3x).


Future Growth

How is Athens Medical C.S.A forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Athens Medical C.S.A has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Athens Medical C.S.A performed over the past 5 years?

25.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IATR has high quality earnings.

Growing Profit Margin: IATR became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: IATR has become profitable over the past 5 years, growing earnings by 25.9% per year.

Accelerating Growth: IATR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: IATR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (45.5%).


Return on Equity

High ROE: IATR's Return on Equity (13.6%) is considered low.


Financial Health

How is Athens Medical C.S.A's financial position?


Financial Position Analysis

Short Term Liabilities: IATR's short term assets (€170.0M) do not cover its short term liabilities (€238.7M).

Long Term Liabilities: IATR's short term assets (€170.0M) exceed its long term liabilities (€100.0M).


Debt to Equity History and Analysis

Debt Level: IATR's net debt to equity ratio (89.5%) is considered high.

Reducing Debt: IATR's debt to equity ratio has reduced from 247.1% to 153.6% over the past 5 years.

Debt Coverage: IATR's debt is not well covered by operating cash flow (14.3%).

Interest Coverage: IATR's interest payments on its debt are well covered by EBIT (4.9x coverage).


Balance Sheet


Dividend

What is Athens Medical C.S.A current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IATR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IATR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IATR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IATR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: IATR is not paying a notable dividend for the Greek market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IATR's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Vassilios Apostolopoulos

no data

Tenure

Dr. Vassilis G. Apostolopoulos serves as Chief Executive Officer of Athens Medical Center SA. and served as its Vice President. Dr. Apostolopoulos serves as a Director of Athens Medical Center SA.He serve...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Athens Medical C.S.A.'s employee growth, exchange listings and data sources


Key Information


Number of Employees


Location

  • Athens Medical C.S.A.
  • 5-7 Distomou Street
  • Maroussi
  • Athens
  • 15125
  • Greece

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/26 21:19
End of Day Share Price2021/11/26 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.